- Filed
- Oct 29, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2020 · Oct 23, 2020 | 33.59M sh |
| Shares Diluted | Q3 2020 · Sep 30, 2020 | 33.7M sh |
| Shares Diluted | Q3 2020 · Sep 30, 2020 | 33.6M sh |
| Shares Diluted | Q3 2020 · Sep 30, 2019 | 33.5M sh |
| Shares Diluted | Q3 2020 · Sep 30, 2019 | 33.4M sh |
| Dividends Paid | Q3 2020 · Sep 30, 2020 | $0 |
| Dividends Paid | Q3 2020 · Sep 30, 2019 | $17M |
| Capex | Q3 2020 · Sep 30, 2020 | $8M |
| Capex | Q3 2020 · Sep 30, 2020 | $25M |
| Capex | Q3 2020 · Sep 30, 2019 | $11M |
| Capex | Q3 2020 · Sep 30, 2019 | $60M |
| Operating Cash Flow | Q3 2020 · Sep 30, 2020 | −$17M |
| Operating Cash Flow | Q3 2020 · Sep 30, 2019 | $89M |
| Cash And Equivalents | Q3 2020 · Sep 30, 2020 | $64M |
| Cash And Equivalents | Q3 2020 · Dec 31, 2019 | $105M |
| Stockholders Equity | Q3 2020 · Sep 30, 2020 | −$177M |
| Stockholders Equity | Q3 2020 · Jun 30, 2020 | −$189M |
| Stockholders Equity | Q3 2020 · Mar 31, 2020 | −$131M |
| Stockholders Equity | Q3 2020 · Dec 31, 2019 | −$72M |
| Stockholders Equity | Q3 2020 · Sep 30, 2019 | $152M |
| Stockholders Equity | Q3 2020 · Jun 30, 2019 | $126M |
| Stockholders Equity | Q3 2020 · Mar 31, 2019 | $153M |
| Stockholders Equity | Q3 2020 · Dec 31, 2018 | $178M |
| Current Liabilities | Q3 2020 · Sep 30, 2020 | $595M |
| Current Liabilities | Q3 2020 · Dec 31, 2019 | $893M |
| Total Liabilities | Q3 2020 · Sep 30, 2020 | $1.65B |
| Total Liabilities | Q3 2020 · Dec 31, 2019 | $1.72B |
| Current Assets | Q3 2020 · Sep 30, 2020 | $725M |
| Current Assets | Q3 2020 · Dec 31, 2019 | $788M |
| Total Assets | Q3 2020 · Sep 30, 2020 | $1.47B |
| Total Assets | Q3 2020 · Dec 31, 2019 | $1.65B |
| Eps Diluted | Q3 2020 · Sep 30, 2020 | −$3.29 |
| Eps Diluted | Q3 2020 · Sep 30, 2020 | −$6.71 |
| Eps Diluted restated | Q3 2020 · Sep 30, 2019 | $0.66 |
| Eps Diluted restated | Q3 2020 · Sep 30, 2019 | −$3.82 |
| Eps Basic | Q3 2020 · Sep 30, 2020 | −$3.29 |
| Eps Basic | Q3 2020 · Sep 30, 2020 | −$6.71 |
| Eps Basic restated | Q3 2020 · Sep 30, 2019 | $0.66 |
| Eps Basic restated | Q3 2020 · Sep 30, 2019 | −$3.82 |
| Sga Expense | Q3 2020 · Sep 30, 2020 | $64M |
| Sga Expense | Q3 2020 · Sep 30, 2020 | $200M |
| Sga Expense | Q3 2020 · Sep 30, 2019 | $88M |
| Sga Expense | Q3 2020 · Sep 30, 2019 | $253M |
| Net Income | Q3 2020 · Sep 30, 2020 | −$111M |
| Net Income | Q3 2020 · Sep 30, 2020 | −$226M |
| Net Income | Q3 2020 · Jun 30, 2020 | −$63M |
| Net Income | Q3 2020 · Mar 31, 2020 | −$52M |
| Net Income restated | Q3 2020 · Sep 30, 2019 | $23M |
| Net Income restated | Q3 2020 · Sep 30, 2019 | −$127M |
| Net Income restated | Q3 2020 · Jun 30, 2019 | −$25M |
| Net Income restated | Q3 2020 · Mar 31, 2019 | −$125M |
| Operating Income | Q3 2020 · Sep 30, 2020 | −$46M |
| Operating Income | Q3 2020 · Sep 30, 2020 | −$146M |
| Operating Income | Q3 2020 · Sep 30, 2019 | −$9M |
| Operating Income | Q3 2020 · Sep 30, 2019 | −$44M |
| Revenue | Q3 2020 · Sep 30, 2020 | $628M |
| Revenue | Q3 2020 · Sep 30, 2020 | $1.86B |
| Revenue | Q3 2020 · Sep 30, 2019 | $834M |
| Revenue | Q3 2020 · Sep 30, 2019 | $2.55B |